Program for the 2009 Pacific Drug Safety Summit Announced, Registration Opens

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) August 12, 2009 -- Emeryville, CA (August 11, 2009) - BioSoteria, Inc. a leading provider of drug safety and risk management consulting services and training, announces the release of the Scientific Program and opening of conference registration for the third annual Pacific Drug Safety Summit, to be held at the Mission Bay Conference Center at UCSF, San Francisco, on September 25, 2009.

Since its inception, the Pacific Drug Safety Summit has grown to be one of the largest and most successful West Coast drug safety and pharmacovigilance conferences and networking events. Drug safety professionals and service providers alike keep coming back to PDSS each year due to the quality of the presentations, the diversity of the speakers and topics, and the opportunity to network with more than 100 drug safety practitioner attendees and numerous vendors sponsoring the event.
Scientific Program
This year’s event offers eight contemporary topics presented by internationally known thought-leaders in drug safety and pharmacovigilance. Topics and invited speakers include the following:

Morning Keynote: Quantitative Safety Signal Detection: CIOMS Working Group VIII
Andrew Bate, PhD, MA
Director, Quantitative Epidemiologist, Pfizer, Inc.

Quantitative Risk Benefit Assessment
Paul Coplan, Sc.D, MBA
Senior Director, Risk Management, Global Safety Surveillance and Epidemiology, Wyeth Pharmaceuticals

Religion and Politics: Controversial issues in Data Monitoring Committees
David Kerr, MS, Project Director, Axio Research

Use of Electronic Health Record Data in Pharmacovigilance
Robert Dubois, MD, PhD
Chief Medical Officer, Cerner Life Sciences

Afternoon Keynote: International Drug Safety Landscape: Challenge and an Opportunity for Change
Rebecca Wang MD, FRCP, FACC
Head, Regional Center, Asia Pacific Pharma Development, Drug Safety Operation, Roche

Online Capture of AEs from Call Centers and Import into Safety Systems
Brian Dinardo
Partner, Foresight Group

Risk Management Plan (RMP) for Extraneal
Robin Geller, PhD
Director of Risk Management, Global Pharmacovigilance, Baxter Healthcare Corporation

Post-marketing Studies and Registries Associated with REMS
Cathy Sigler, DVM, PhD
Sr. Director, Safety, Epidemiology, Registries, & Risk Management, United BioSource Corporation

Attendees will have the opportunity throughout the event to participate in networking breaks and a panel discussion, as well as interact with a diverse assemblage of drug safety and pharmacovigilance attendees and sponsoring vendors. Breakfast and lunch will also be served and is included in the registration fee.
Registration
Due to the generous support of the conference sponsors, BioSoteria is able to again offer an affordable registration fee for conference attendees. The early bird registration fee to attend this full, one-day conference is $225 for those who register by Monday, August 31; the full registration fee is $295 for those who register after August 31.